Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese Population

NCT06763887 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT06763887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06763887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese Population
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Completed
Start date
November 15, 2023
Completion date
June 30, 2024
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid